HUM
HumanaPrevious close
414.50
Change
−3.06 / −0.73%
P/E (TTM) ?
38.7
Market Cap
$49.5B
1M
+8.63%
S&P 500 −0.91% over same period
Volume / Avg Volume
889K / 1.3M
0.67× average
Latest earnings analysisFY2026 Q2Reported 2026-07-29
Humana 2Q26: revenue up 26.2%, adjusted EPS $7.61, guidance held
Humana's second quarter was a revenue story with a profit caveat: sales rose 26.2% to $40.867 billion and adjusted EPS of $7.61 beat the $7.29 consensus, while the Insurance benefit ratio worsened to 91.2% from 89.9%. Management held full-year adjusted EPS at 'at least $9.00' but cut GAAP EPS guidance to 'at least $6.52'. View: Neutral, because growth is real but the Star Ratings hit and the second-half guidance gap keep us cautious.
Read the full analysis →Revenue$40.87BYoY +26.20%
EPS (non-GAAP)$7.61Beatest. $7.29
Next-quarter revenue guidance$160.00BYoY +291.50%
Next-day move+0.34%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-29 | $40.9B | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-29 | $39.6B | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-02-11 | $130B | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-11-05 | $32.6B | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-30 | $32.4B | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-30 | $32.1B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 89 of its 5-year rangeExpensive
5-year range 16.1 – 42.1 · Median 21.3
Last 4 quarters: $249M in buybacks + $429M in dividends, 1.37% of market cap combined
P/E (TTM)
38.7
P/B
2.6
P/S
0.3
Dividend Yield
0.68%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.8% on average on the first trading day after, rising 2 times
Most recent +0.34%
Volatility & Correlation
1-year beta 0.60 · Correlation with S&P 500 0.16Low beta
Annualized volatility 47% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q1 | 39.65 | +23.5% | — | 1.19 | 9.83 |
| FY2025 Q4 | 32.52 | +11.3% | — | -0.80 | -6.59 |
| FY2025 Q3 | 32.65 | +11.1% | — | 0.20 | 1.62 |
| FY2025 Q2 | 32.39 | +9.6% | — | 0.55 | 4.51 |
| FY2025 Q1 | 32.11 | +8.4% | — | 1.24 | 10.30 |
| FY2024 Q4 | 29.21 | +10.4% | — | -0.69 | -5.73 |
| FY2024 Q3 | 29.40 | +11.3% | — | 0.48 | 3.98 |
| FY2024 Q2 | 29.54 | +10.4% | — | 0.68 | 5.62 |
| FY2024 Q1 | 29.61 | +10.7% | — | 0.74 | 6.11 |
| FY2023 Q4 | 26.46 | +17.9% | — | -0.54 | -4.24 |
| FY2023 Q3 | 26.42 | +15.9% | — | 0.83 | 6.71 |
| FY2023 Q2 | 26.75 | +13.0% | — | 0.96 | 7.66 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| HUM | 38.7 | +23.5% | — | +8.63% | Neutral |
| LLY | 50.2 | +38.6% | 83.9% | +22.51% | Bullish |
| JNJ | 41.3 | +5.9% | 68.1% | +3.20% | Bullish |
| ABBV | 81.4 | +10.2% | 74.7% | +12.73% | Bullish |
| UNH | 23.0 | +0.4% | 88.1% | +10.87% | Bullish |
| MRK | 117.2 | +5.1% | 73.5% | +2.90% | Neutral |
| TMO | 36.4 | +9.1% | — | +3.25% | Neutral |
| AMGN | 28.5 | +9.5% | 72.0% | +10.56% | Bullish |
| GILD | — | +6.8% | 81.1% | +14.51% | Neutral |